Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes
- 17 June 1999
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 44 (2) , 124-130
- https://doi.org/10.1007/s002800050956
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: